[T.S.R:18309] Jubilant Life Sciences Ltd.- Financial Results for the quarter and 9 months ended December 31, 2011

FYI

 

Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.

 

Nothing in this article is, or should be construed as, investment advice.

 

 

 

 

 

----- Forwarded Message -----
From: Nidhi Aggarwal - IR <Nidhi_aggarwal@jubl.com>
To:
Sent: Monday, February 6, 2012 3:12 PM
Subject: Jubilant Life Sciences Ltd.- Financial Results for the quarter and 9 months ended December 31, 2011

 

Dear All,

 

Jubilant Life Sciences Board of Directors met today to approve the financial results of the Company for the quarter and 9 months ended December 31, 2011. Please find attached the Press Release as well as the Earnings presentation for the period. Financial highlights of the results are:

 

•         Net Sales at Rs. 1,087crs for Q3'FY12, grew 25% YoY

•         Record highest ever sales in a quarter

•         Revenue from Products Business at Rs. 867crs, grew 24%

•         Revenue from Services Business at Rs. 220crs, grew 32%

 

•         EBITDA at Rs. 212crs in Q3'FY12, up 58% YoY

•         Margins at 19.5% for the quarter, grew 405 bps

•         Product Business Margins at 23.6%, higher by 77 bps

•         Services Business Margins at 10.9%, depict turnaround

 

•         Revenue of Rs. 3,080crs for 9M'FY12, grew 21% YoY

•         Highest ever sales in Nine Month period

•         Revenue from Products Business at Rs. 2,439crs, grew 23%

•         Revenue from Services Business at Rs. 640crs, grew 15%

 

 

•         EBITDA at Rs. 643crs in 9M'FY12, up 50% YoY

•         Margins at 20.9% for the 9 months period, grew 396bps

•         Product Business margins at 24.5%, higher by 121bps

 

 

Look forward to your participation in the call at 1600hrs, India Time today evening.

 

Thanks and regards

 

Nidhi Aggarwal - IR | Senior Vice President - Investor Relation

Jubilant Life Sciences Ltd.
Plot No. 1A, Sector 16A, Noida - 201301
T: 911204361002 |M: 919810197755
E-mail : Nidhi_aggarwal@jubl.com |Web Site : www.jubl.com

PPlease consider the environment before printing this email

The information contained in this electronic message and in any attachments to this message is confidential, legally privileged and intended only for use by the person or entity to which this electronic message is addressed. If you are not the intended recipient, and have received this message in error, please notify the sender and system manager by return email and delete the message and its attachments and also you are hereby notified that any distribution, copying, review, retransmission, dissemination or other use of this electronic transmission or the information contained in it is strictly prohibited. Please note that any views or opinions presented in this email are solely those of the author and may not represent those of the Company or bind the Company. Any commitments made over e-mail are not financially binding on the company unless accompanied or followed by a valid purchase order. This message has been scanned for viruses and dangerous content by Mail Scanner, and is believed to be clean. The Company accepts no liability for any damage caused by any virus transmitted by this email.
www.jubl.com

--
For Anything related with Stock market be Online at
http://www.niftyviews.com/
 
Get free updates on your mobile phone. Sms "Join TSR " and send to 09223492234
 
FOR TRIAL STOCK/NIFTY/OPTION CALLS
 
 
You received this message because you are subscribed to Google Group "STOCKRESEARCHER" group.
To post to this group, send an email to STOCKRESEARCHER@googlegroups.com
 
To unsubscribe email
Stockresearcher-unsubscribe@googlegroups.com
 
for more info visit
http://groups.google.com/group/STOCKRESEARCHER?hl=en-GB
.
This is Not a Spam Mail.
Disclaimer :-
"The opinions expressed by the members on this board are based on
their individual experience and perceptions and to share information
with other members with the best of intentions to help fellow members
in investment decisions as equity investment is a risky venture."